Hypoxic augmentation: The tale of a strange contraction

Area of Science:

• Cardiovascular Physiology
• Cellular Metabolism
• Molecular Pharmacology

Background:

• Acute hypoxia augments venoconstrictor responses, initially linked to anaerobic glycolysis.
• This phenomenon extends to arterial preparations and involves vascular smooth muscle calcium handling.
• Endothelium-dependent mechanisms require nitric oxide (NO) production by endothelial nitric oxide synthase (eNOS).

Purpose of the Study:

• To elucidate the mechanistic details of hypoxia-induced augmentation of vascular contractility.
• To investigate the role of nitric oxide signaling and cyclic nucleotide production under hypoxic conditions.
• To explore the involvement of soluble guanylyl cyclase (sGC) and its non-canonical activity.

Main Methods:

• In vitro experiments on isolated vascular preparations (veins and arteries).
• Investigation of cellular mechanisms including calcium handling and anaerobic metabolism.
• Analysis of nitric oxide production, eNOS activity, and sGC activation.

Main Results:

• Hypoxia augments vascular contractility through anaerobic glycolysis.
• Endothelial nitric oxide synthase (eNOS) and soluble guanylyl cyclase (sGC) are crucial.
• During hypoxia, sGC produces 3',5'-cyclic inosine monophosphate (cIMP) instead of 3',5'-cyclic guanosine monophosphate (cGMP).
• This non-canonical cyclic nucleotide (cIMP) facilitates vascular smooth muscle contraction.
• NAD(P)H:quinone oxidoreductase 1 (NQO-1) appears to be involved in the biased sGC activity.

Conclusions:

• Acute hypoxia triggers a non-canonical signaling pathway involving eNOS and sGC.
• The production of cIMP, rather than cGMP, by sGC under hypoxia mediates enhanced vascular contractility.
• The interaction between hypoxia, anaerobic metabolism, NQO-1, and biased sGC activity requires further investigation.